Results for National Health Program 3 - NHP oncology

Chemical substance: tisagenlecleucel

ATC code: L01XL04 • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Antineoplastic cell and gene therapy

Chemical substance: lutetium (177Lu) vipivotide tetraxetane

ATC code: V10XX05 • Various | Other therapeutic radiopharmaceuticals | Various therapeutic radiopharmaceuticals

Chemical substance: ripretinib

ATC code: L01EX19 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: tremelimumab

ATC code: L01FX20 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Chemical substance: avapritinib

ATC code: L01EX18 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: avapritinib

ATC code: L01EX18 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: avapritinib

ATC code: L01EX18 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: avapritinib

ATC code: L01EX18 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: gilteritinib

ATC code: L01EX13 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: ivosidenib

ATC code: L01XM02 • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Isocitrate dehydrogenase (IDH) inhibitors

Chemical substance: avapritinib

ATC code: L01EX18 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: midostaurin

ATC code: L01EX10 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Chemical substance: ipilimumab

ATC code: L01FX04 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Chemical substance: tebentafusp

ATC code: L01XX75 • Antineoplastic and immunomodulating agents | Other antineoplastic agents

Chemical substance: inotuzumab ozogamycin

ATC code: L01FB01 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd22 (clusters of differentiation 22) inhibitors

Chemical substance: polatuzumab vedotin

ATC code: L01FX14 • Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Chemical substance: dinutuximab beta

ATC code: L01XC16 • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Monoclonal antibodies

Chemical substance: glasdegib

ATC code: L01XJ03 • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Hedgehog pathway inhibitors

Chemical substance: glasdegib

ATC code: L01XJ03 • Antineoplastic and immunomodulating agents | Other antineoplastic agents | Hedgehog pathway inhibitors

Chemical substance: ibrutinib

ATC code: L01EL01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Bruton's tyrosine kinase (BTK) inhibitors